A recent study revealed that, after 100 days of selective serotonin reuptake inhibitor treatment, methylation of promoter CpG sites of BDNF was significantly decreased, reducing depression scores after this treatment [49]. This evidence concerns the gene BDNF and depressive symptom measurement.